Makers of OTC Medicines Applaud Gov. Jindal for Signing HB 514

Louisiana to be sixth state to pass legislation limiting the sale of over-the-counter cough medicines containing dextromethorphan to minors

Washington, D.C. (May 28, 2014) — The Consumer Healthcare Products Association (CHPA) issued the following statement applauding Louisiana Governor Bobby Jindal for signing H.B. 514 in to law.  H.B. 514, sponsored by state Representative Cameron Henry, prohibits minors from purchasing over-the-counter (OTC) cough medicines containing dextromethorphan (DXM) without a prescription.

“Over-the-counter cough medicine abuse raised my concerns because of the easy access teens have to the medicines,” said Henry. “Prohibiting teens from purchasing these medicines on their own, without their parents’ knowledge, is one way to deter teens from engaging in this behavior.

“According to the 2013 National Institute on Drug Abuse’s (NIDA) Monitoring the Future Survey, approximately one in 25 teens abuses DXM to get high.

“The manufacturers of over-the-counter medicines are grateful to Rep. Henry for his efforts to prevent teen cough medicine abuse in Louisiana,” said CHPA President and CEO, Scott Melville. “The passage of this legislation indicates the growing support in our country for laws to prohibit the sale of DXM to minors, which helps parents prevent their teens from abusing cough medicine. While there is no one solution to this problem, restricting access is an important part of prevention along with encouraging parents to talk to their teens about the risks and to safeguard the medicines in their home.”

CHPA also supports a national age-18 sales restriction bill introduced in the U.S. Senate and U.S. House of Representatives, the Preventing Abuse of Cough Treatments (PACT) Act of 2013 (S. 644 and H.R. 3969)
For more information on preventing teen abuse of OTC cough medicines, visit

Contact Jenni Terry 202.429.9260


The Consumer Healthcare Products Association (CHPA) is the 133-year-old trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines and dietary supplements. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system $6-$7, contributing a total of $102 billion in savings each year. CHPA is committed to promoting the increasingly vital role of over-the-counter medicines and dietary supplements in America’s healthcare system through science, education, and advocacy.